AQR Capital Management - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 73 filers reported holding OVID THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$1,180,000
+140.3%
301,767
+147.2%
0.00%
+100.0%
Q1 2021$491,000
+601.4%
122,059
+301.7%
0.00%
Q4 2020$70,000
-75.9%
30,387
-40.0%
0.00%
Q3 2020$291,00050,6340.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
TLS Advisors LLC 1,380,346$3,51618.08%
Madison Avenue Partners, LP 3,104,603$8,009,8761.72%
BVF INC/IL 6,851,051$17,675,7120.65%
CHI Advisors LLC 864,822$2,231,2410.59%
EcoR1 Capital, LLC 6,117,400$15,782,8920.51%
Rubric Capital Management LP 7,001,124$18,062,9000.47%
Artal Group S.A. 2,500,000$6,4500.38%
Tejara Capital Ltd 118,791$306,4810.16%
DCF Advisers, LLC 68,264$176,1200.11%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 827,580$2,135,1560.06%
View complete list of OVID THERAPEUTICS INC shareholders